Bobby Brooke

Bobby Brooke is the CEO of Intervene Immune, Inc, a non-profit biotechnology company that is developing approaches for the safe regeneration of the human immune system. It is aiming to develop low-cost methods that are safe and reliable and can be made widely available to the general public. The company is seeking to reverse age-related immunosenescence, where the immune systems fails with advancing age, and is a major reason we age and get age-related diseases.

Related Organizations

Articles from this author

September 17, 2025

Lifespan Research Institute Launches Public Longevity Group

[Mountain View, September 17, 2025] — Lifespan Research Institute (LRI) today announced the launch of the Public Longevity Group (PLG), a new initiative focused on bridging the cultural gap between scientific breakthroughs in aging and their public acceptance. To kickstart its work, PLG has opened a crowdfunding campaign to develop tools that measure and strengthen...